Bimepolizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bimepolizumab, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma [Phase 2]